Continuous glucose monitoring (CGM) uses a small sensor worn under the skin to measure glucose in the fluid between your cells every few minutes, giving you an unbroken curve of your blood sugar across the day and night instead of a few scattered fingerstick dots. Its real value is not the number on screen right now — it is the pattern: how sharply a particular meal lifts you, how many hours of your day sit inside a healthy range, and which daily habit is quietly pushing your curve up. This guide explains how the sensor works, how to read your report in plain language, and what it can teach you about your own food — with one important caveat: this is educational information, not a substitute for your doctor's advice.
What is continuous glucose monitoring, exactly?
A CGM system has three parts: a hair-thin sensor filament inserted just under the skin (usually on the back of the upper arm or the abdomen), a small transmitter that sits on top of the skin, and an app or reader that displays the data. Most sensors are worn for roughly 10 to 15 days depending on the brand, and report a reading every few minutes — around 288 readings a day on devices that sample every five minutes.
How does the sensor actually measure glucose?
Here is the detail most beginners miss: the sensor does not measure blood. It measures glucose in the interstitial fluid — the fluid surrounding the cells in the fatty layer beneath your skin. As Cleveland Clinic explains it, glucose reaches your bloodstream first and then leaks into the interstitial fluid. The practical consequence is a lag of several minutes between what is happening in your blood and what appears on your screen.
That lag is not a defect — it explains everyday moments. If you do a fingerstick during a fast post-meal rise, the finger may read higher than the sensor; during a fast fall, the opposite. The golden rule: when your symptoms do not match the screen, confirm with a fingerstick, especially if you feel low.
How is it different from fingerstick testing?
A fingerstick gives you one accurate photograph of a moment. A sensor gives you the whole film. The decisive difference is everything between the snapshots: with three fingersticks a day you completely miss post-meal peaks, overnight lows, and the dawn rise. A sensor shows those gaps, and adds something a fingerstick cannot — direction: is glucose rising, falling, or flat, and how fast?
Who is CGM recommended for?
The American Diabetes Association (ADA) notably widened the list in its Standards of Care in Diabetes—2026. The Standards now recommend starting CGM immediately at diabetes onset for anyone using insulin or medications that can cause low glucose, and expanded the recommendation to include:
- Adults with type 2 diabetes even when they are not using insulin, following accumulating evidence of benefit.
- Young children with type 1 diabetes.
- People with presymptomatic type 1 diabetes (stages 1 and 2).
- Pregnant individuals with type 2 diabetes and gestational diabetes.
The Standards also added a meaningful requirement (Section 7.3): healthcare professionals must provide initial and ongoing training on interpreting the data, handling skin reactions, and understanding the factors that affect accuracy. The message is clear — the device is a tool, and reading it is a skill you learn.
For people without diabetes, the landscape changed when the U.S. Food and Drug Administration (FDA) cleared the first over-the-counter glucose biosensor in March 2024, with others following. These are aimed at adults not using insulin, and they are an awareness tool, not a diagnostic one: diabetes is not diagnosed by a sensor, but by validated laboratory tests your doctor orders.
Reading your report: five numbers are enough
At the end of each 14-day wear, your app produces a standardized report. You do not need to understand all of it — five numbers will carry you.
1) Time in Range (TIR)
This is the percentage of time your glucose stayed between 70 and 180 mg/dL, and it is the single most important line in the report. According to the International Consensus on Time in Range (Battelino et al., Diabetes Care, 2019), the goal for most adults with type 1 or type 2 diabetes is at least 70% of the day — roughly 17 hours. That target corresponds to an A1C of approximately 7%.
2) Time below range
In the short term, lows are more dangerous than highs, so they get two separate targets: less than 4% of the time below 70 mg/dL (about one hour) and less than 1% below 54 mg/dL (about 15 minutes). If you exceed either, that is the first thing to raise with your doctor — before any conversation about lowering your average.
3) Time above range
Targets here are under 25% of the time above 180 mg/dL (about 6 hours) and under 5% above 250 mg/dL. The ADA 2026 Standards sort glucose into five clear bands: very high above 250, high from 180 to 250, in range from 70 to 180, low from 54 to 69, and very low below 54.
4) Mean glucose and the Glucose Management Indicator (GMI)
Your report shows a mean glucose, from which it calculates the Glucose Management Indicator (GMI) using the equation developed by Bergenstal and colleagues in Diabetes Care (2018): GMI (%) = 3.31 + (0.02392 × mean glucose in mg/dL). And here is a warning many people never hear: GMI is not your laboratory A1C. In validation data, only about 20% of people had the two values agree within 0.1% — meaning the majority see a meaningful gap. Use GMI to track your own trend, not to overrule a lab test.
5) Coefficient of Variation (CV)
This measures how jagged your curve is: gentle hills or sharp spikes? A CV of 36% or lower is the usual guidance. Two people can share an identical average while one runs steady and the other swings wildly — and those are not the same thing.
One last note on reading: for a report to mean anything, the international consensus recommends 14 days of data with at least 70% sensor coverage. A three-day report is not a basis for a decision.
Why "time in range" matters more than you think
For decades A1C was the sole judge. It is an excellent measure, but it is a three-month average, and averages hide the story. The ADA 2026 Standards state plainly that A1C "does not provide a measure of glycemic variability or hypoglycemia." Two people can both post 7.5% while one has a calm day and the other swings between 50 and 300 to arrive at the same mean.
Those same Standards recognize time in range as a valid measure of glycemic control, noting that a 5% increase in TIR is associated with reduced risk of albuminuria, diabetic retinopathy, and neuropathy. In other words, an extra hour and a quarter inside range each day is not a cosmetic detail.
On hard outcomes, the MOBILE trial (Martens et al., JAMA, 2021) is among the clearest evidence: 175 adults with type 2 diabetes on basal insulin only, mean age 57, starting A1C 9.1%. After eight months, A1C in the CGM group fell from 9.1% to 8.0%, versus 9.0% to 8.4% with fingerstick monitoring (adjusted difference 0.4%; 95% CI, 0.1% to 0.8%). More striking: time in range reached 59% versus 43%, and time above 250 mg/dL dropped to 11% versus 27%.
These numbers carry particular weight locally. According to the International Diabetes Federation's IDF Diabetes Atlas (2025 edition, 2024 data), adult diabetes prevalence in Saudi Arabia is around 23.1% — roughly 5.3 million adults — of whom about 2.33 million are undiagnosed, more than 43% of everyone living with the condition. Understanding your patterns, then, is not a technological luxury.
What can a sensor teach you about your food?
What surprises new users most is how personal their food responses are. In a study published in Cell in 2015, Zeevi and colleagues followed 800 people across 46,898 meals and 5,435 days of continuous glucose monitoring, collecting over 1.5 million readings. When they gave everyone an identical standardized meal containing 50 g of carbohydrate, the result was striking: the bottom 10% of responders stayed below 15 units (mg/dL × h), while the top 10% exceeded 79 units — more than a fivefold difference for literally the same plate. The team then confirmed the finding in a blinded randomized crossover trial in 26 participants, where personalized plans genuinely lowered post-meal responses.
The practical takeaway: glycemic index tables are a useful general guide, but they are not a prophecy about your body. That said — and this matters — individual variability does not mean every option is equal. Refined, high-carbohydrate foods provoked the largest curves in the overwhelming majority, and a second important study reinforces the point.
In PLOS Biology (2018), Hall and colleagues put sensors on 57 people, 38 of whom were classified as normoglycemic by standard tests. The researchers sorted the patterns into three "glucotypes": low, moderate, and severe variability. The surprise: 24% of the normoglycemic group fell into the severe pattern, reaching prediabetic glucose levels up to 15% of the time and diabetic levels 2% of the time — none of which was visible in routine labs. And when three standardized breakfasts were tested, 60% of responses to cereal with milk were classified as severe variability, while a peanut butter sandwich and a protein bar produced calmer curves.
The meal experiment: how to test one dish properly
- Start from a stable baseline: test after at least 3–4 hours without food, and record the reading immediately before eating.
- Change one variable only: same dish, same portion, same time of day — then change a single thing (the type of bread, say) next time.
- Watch for two hours: note the peak, and how many minutes it takes to return near your starting point.
- Repeat two or three times: sleep, stress, and movement all shift the result. Once is not evidence.
- Judge two things: how high the peak went, and how fast you came back. A good meal for you is one that neither lifts you far nor keeps you up long.
Five common beginner mistakes
- Chasing every number: a modest post-meal rise is normal physiology, not a personal failure. Look at the two-week report, not the 2 p.m. reading.
- Ignoring the lag: comparing sensor to fingerstick during a rapid rise or fall produces an expected gap, not evidence of a faulty sensor.
- Compression lows: sleeping on the arm wearing the sensor can produce a false low that disappears when you change position.
- Alarm fatigue: Cleveland Clinic cautions that frequent alerts can worsen diabetes-related distress. Set realistic thresholds with your care team.
- Forgetting medication effects: some substances can affect the accuracy of certain sensors, including acetaminophen (paracetamol), high-dose vitamin C, and hydroxyurea. Read your device's instructions.
Practical tips for your first 14 days
- 🩺 Do not change any medication based on the sensor alone. Every insulin or tablet adjustment goes through your doctor.
- 📓 Log only three things: what you ate, when you moved, and how you slept. Those three explain most of what you will see.
- 🚶 Try a 10–15 minute walk after a meal and compare the curve with a day without one. Many people see the difference with their own eyes for the first time.
- 🥗 Try meal sequencing: eat vegetables and protein before the starch within the same meal, and compare.
- 😴 Watch a short night of sleep: you will usually notice a higher morning curve the next day.
- 🧊 Keep a fingerstick meter as a second line of defence whenever a reading does not match how you feel.
Who should be careful, and when to consult your doctor
CGM is broadly safe, but it is not a solo decision in every situation:
- People on insulin or medications that cause lows: setup and alarm thresholds belong with your medical team, not to guesswork.
- Pregnancy: glucose targets in pregnancy differ from general adult targets and are set medically.
- Sensitive skin: adhesive reactions can occur; rotate sites and see a professional if irritation persists.
- Anyone with anxiety or a difficult relationship with food: constant number-watching can become obsessive for some; discuss it with a professional before starting.
- People without diabetes: a sensor offers awareness, not a diagnosis. If you repeatedly see concerning readings, the right next step is a validated test with your doctor.
This article is for educational purposes only and does not replace medical advice. Consult your doctor or a registered dietitian before changing your diet or medication, or before starting any monitoring device.
From the reading to the plate: turning data into choices
After two weeks of monitoring, most people arrive at the same conclusion: the biggest jumps come from meals built on refined starch and sugar — white bread, sweetened breakfast cereal, traditional desserts. Which makes the question practical: what do you replace them with, without losing the daily ritual you enjoy?
At Bakery 8 (مخبز ثمانية) in Riyadh, Saudi Arabia, we built our products on exactly this logic — almond flour instead of white flour, and no added sugar — so they can serve as a gentler baseline while you test your own meals:
- Samoli bread, cloud bread and toast — a practical stand-in for white bread at breakfast and dinner, ideal for the "same sandwich, different bread" experiment.
- Keto granola — a direct alternative to cereal with milk, which is precisely the breakfast that produced the most severe responses in the PLOS Biology study.
- Crackers and manakish — a between-meetings snack instead of crisps and sweetened biscuits.
- Sugar-free chocolate — for the evening sweet craving, the moment most people lose their footing.
The point is not that any product "treats" anything — it does not — but that giving yourself better options makes the number on your screen calmer without making you feel deprived. To go deeper, read our companion pieces on prediabetes and how to reverse it and sleep and blood sugar.
Frequently asked questions
Can I use a CGM if I don't have diabetes?
Yes. Since March 2024 the FDA has cleared over-the-counter glucose biosensors for adults who do not use insulin. But the device is a pattern-awareness tool, not a diagnostic one — diabetes and prediabetes are diagnosed with validated laboratory tests ordered by a doctor.
What is the difference between GMI and A1C?
GMI is calculated by your app from your sensor's mean glucose over a short window; A1C is a blood test reflecting roughly three months. In validation data only about 20% of people saw the two agree within 0.1%. Treat GMI as a trend indicator, never as a replacement for the lab result.
How many days of data do I need before drawing conclusions?
The International Consensus on Time in Range recommends 14 days of data with at least 70% sensor coverage. Anything less can mislead, because a single badly slept or unusually busy day is enough to distort the entire average.
Why does my sensor disagree with my fingerstick?
Because the sensor measures glucose in interstitial fluid rather than blood, and glucose reaches the bloodstream first before leaking into that fluid. The lag is most visible during rapid rises and falls. When a reading conflicts with your symptoms, trust the fingerstick.
Does a rise after every meal mean something is wrong?
No. A moderate post-meal rise is normal. What warrants attention is very high peaks, slow returns to baseline, or spending more than 25% of the day above 180 mg/dL. Discuss your overall pattern with your doctor rather than judging a single reading.
Can a sensor tell me which bread is best for me?
It can tell you which option lifts you least and returns you fastest — and that is highly individual, as the 2015 Cell study showed. Try the same sandwich with two different breads on two comparable days, and compare the peak and the recovery time.
The bottom line
Continuous glucose monitoring does not change your body, but it ends the guesswork. Once you see with your own eyes that a short walk after dinner flattens your peak, that a short night raises your morning, and that a different bread draws a different curve, daily decisions get far easier. Start with two weeks of data and focus on one number: time in range. And when you are looking for options that are gentler on your curve, browse the Bakery 8 range made with almond flour and no added sugar — healthy and delicious.
References
- American Diabetes Association. "7. Diabetes Technology: Standards of Care in Diabetes—2026." Diabetes Care, 2026;49(Suppl. 1):S150–S178.
- American Diabetes Association. "6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes—2026." Diabetes Care, 2026;49(Suppl. 1):S132–S149.
- Battelino T, Danne T, Bergenstal RM, et al. "Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range." Diabetes Care, 2019;42(8):1593–1603.
- Martens T, Beck RW, Bailey R, et al. "Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial (MOBILE)." JAMA, 2021;325(22):2262–2272.
- Bergenstal RM, Beck RW, Close KL, et al. "Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring." Diabetes Care, 2018;41(11):2275–2280.
- Zeevi D, Korem T, Zmora N, et al. "Personalized Nutrition by Prediction of Glycemic Responses." Cell, 2015;163(5):1079–1094.
- Hall H, Perelman D, Breschi A, et al. "Glucotypes reveal new patterns of glucose dysregulation." PLOS Biology, 2018;16(7):e2005143.
- Cleveland Clinic. "Continuous Glucose Monitoring (CGM)" — how it works, benefits, and limitations.
- U.S. Food and Drug Administration. "FDA Clears First Over-the-Counter Continuous Glucose Monitor," March 2024.
- International Diabetes Federation. IDF Diabetes Atlas, 2025 edition — Saudi Arabia country data (2024).
Related keywords: continuous glucose monitoring, CGM for beginners, glucose sensor, time in range, glucose management indicator, post-meal blood sugar, glycemic variability, prediabetes, type 2 diabetes, almond flour, keto bread, Bakery 8.